We are live on ! Find out more
CYTXW

Cytori Therapeutics Inc Warrant

Delisted

CYTXW was delisted on the 14th of December, 2018.

3 hedge funds and large institutions have $880K invested in Cytori Therapeutics Inc Warrant in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less funds holding

Funds holding: 63 (-3)

65% less capital invested

Capital invested by funds: $2.48M → $880K (-$1.6M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
3
Holders Change
-3
Holders Change %
-50%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$284K
Name Holding Trade Value Shares
Change
Change in
Stake
SM
1
Sabby Management
Florida
$866K +$284K +378,695 +42%
Creative Planning
2
Creative Planning
Kansas
$14K
AFM
3
Anson Funds Management
Texas
-$914K -450,000 Closed
KLI
4
Kelman-Lazarov Inc
Tennessee
-$159 -200 Closed

CYTXW Hedge Fund Activity: Q4 2016 in Review

3 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Cytori Therapeutics Inc Warrant (CYTXW) for Q4 2016, worth a combined $880K — down 65% from $2.48M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of CYTXW and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Sabby Management, adding an estimated $284K. The largest seller was Anson Funds Management, exiting entirely with an estimated $914K sold.

  • 3 institutional investors held Cytori Therapeutics Inc Warrant (CYTXW) as of Q4 2016, down from 6 in Q3 2016.
  • Funds reported $880K of Cytori Therapeutics Inc Warrant stock for Q4 2016, down 65% quarter-over-quarter.
  • 0 funds opened new Cytori Therapeutics Inc Warrant positions in Q4 2016 and 3 closed out, a net change of -3 holders.
  • The largest Cytori Therapeutics Inc Warrant buyer in Q4 2016 was Sabby Management, an estimated $284K added.
  • The largest Cytori Therapeutics Inc Warrant seller in Q4 2016 was Anson Funds Management, an estimated $914K sold.

Based on aggregated 13F filings for Q4 2016.